Please review the following URL and make sure that it is spelled correctly. Atovaquone/Proguanil (Malarone) Adults: 1 adult tablet daily. Plaquenil help with fatigue Chloroquine-primaquine-phosphate tablets Specific antimalarial drugs • Quinine – Drug of choice for chloroquine-resistant malaria • Lumifantrine, Amodiaquine, Atovaquone – Reserve medication 30. Tuberculosis in pregnancy First-line drugs • Isoniazid • Rifampicin • Ethambutol • Pyrazinamide Contraindicated • Streptomycin 31. Education and information regarding choosing a drug to prevent malaria, including a list of all available drugs and reasons for taking or not taking a certain drug. Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link Medications that can be used for the treatment of malaria in pregnancy include chloroquine, quinine, atovaquone-proguanil, clindamycin, mefloquine avoid in first trimester, sulfadoxine. This drug should be used during pregnancy only if clearly needed and the benefit outweighs the risk.-According to some authorities: Use is considered acceptable. Begin 1-2 days before travel, daily during travel, and for 7 days after leaving. Drug of choice for chloroquine resistant malaria in pregnancy Chloroquine-Resistant Malaria The Journal of Infectious., CDC - Malaria - Travelers - Choosing a Drug to Prevent Malaria What is the shelf life of chloroquine phosphateChloroquine phosphate lethalHydroxychloroquine skinSarcoidosis treatment hydroxychloroquine Some evidence supports the safety of mefloquine in the second and third trimesters, and it therefore remains the drug of choice for chloroquine resistance areas.6 24 Caution is needed with mefloquine in the first trimester because of limited data. Preventing malaria in travellers The BMJ. Which medications are used to treat malaria during pregnancy?. All_antimalarial_drugs TUSOM Pharmwiki. This agent is approved in the United States for the prophylaxis and treatment of mild chloroquine-resistant malaria. It may be a good prophylactic option for patients who are visiting areas with chloroquine-resistant malaria and who cannot tolerate mefloquine. Each tab combines 250 mg of atovaquone and 100 mg of proguanil hydrochloride. In addition, any of the regimens listed below for the treatment of chloroquine-resistant malaria may be used for the treatment of chloroquine-sensitive malaria. Prompt initiation of an effective regimen is vitally important and so using any one of the effective regimens that is readily at hand would be the preferred strategy. Mefloquine is the agent of choice for chloroquine-resistant areas, and evidence suggests it is not associated with an increased risk to the fetus. Although the atovaquone-proguanil drug combination is not currently recommended for use during pregnancy, limited data suggest that it is not harmful to the fetus.